The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial.
Zahra YariMakan CheraghpourSeyed Moayed AlavianMehdi HedayatiHassan Eini-ZinabAzita HekmatdoostPublished in: European journal of clinical nutrition (2020)
In conclusion, our study confirmed that hesperidin and flaxseed supplementation improved glucose and lipid metabolism, while reduced inflammation and hepatic steatosis (controlled attenuation parameter) in NAFLD patients. The synergistic effects of their combination were observed on plasma glucose concentration and HOMA-IR.
Keyphrases
- randomized controlled trial
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- blood glucose
- oxidative stress
- peritoneal dialysis
- study protocol
- prognostic factors
- computed tomography
- type diabetes
- metabolic syndrome
- pet imaging
- drug delivery
- patient reported outcomes
- fatty acid
- patient reported
- glycemic control
- double blind